{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:08:18Z","timestamp":1791317298992,"version":"4.3.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thermostable Newcastle disease virus (NDV) vaccines have been used widely to protect village chickens against Newcastle disease, due to their decreased dependence on cold chain for transport and storage. However, the genetic basis underlying the NDV thermostability is poorly understood. In this study, we generated chimeric viruses by exchanging viral genes between the thermostable TS09-C strain and thermolabile LaSota strain using reverse genetics technology. Evaluations of these chimeric NDVs demonstrated that the thermostability of NDV was dependent on the origin of HN protein. Chimeras bearing the HN protein derived from thermostable virus exhibited a thermostable phenotype and vice versa. Both hemagglutinin and neuraminidase activities of viruses bearing the TS09-C HN protein were more thermostable than those containing LaSota HN protein. Furthermore, the newly developed thermostable virus rLS-T-HN, encoding the TS09-C HN protein in LaSota backbone, induced significantly higher antibody response than the TS09-C virus and conferred complete protection against virulent NDV challenge. Taken together, the data suggest that the HN protein of NDV is a crucial determinant of thermostability and the HN gene from a thermostable NDV could be engineered into a thermolabile NDV vaccine strain for developing novel thermostable NDV vaccine.<\/jats:p>","DOI":"10.1038\/srep22492","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T10:16:19Z","timestamp":1457000179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Molecular basis for the thermostability of Newcastle disease virus"],"prefix":"10.1038","volume":"6","author":[{"given":"Guoyuan","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"BFsrep22492_CR1","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1128\/JCM.42.5.2329-2334.2004","volume":"42","author":"JC Pedersen","year":"2004","unstructured":"Pedersen, J. C. et al. Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002\u20132003 outbreak in California and other recent outbreaks in North America. J Clin Microbiol 42, 2329\u20132334 (2004).","journal-title":"J Clin Microbiol"},{"key":"BFsrep22492_CR2","unstructured":"Lamb, R. A. et al. In Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses (eds Fauquet, C. M. et al.) 655\u2013668 (Elsevier Academic Press, 2005)."},{"key":"BFsrep22492_CR3","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1099\/0022-1317-74-12-2539","volume":"74","author":"M Steward","year":"1993","unstructured":"Steward, M., Vipond, I. B., Millar, N. S. & Emmerson, P. T. RNA editing in Newcastle disease virus. J Gen Virol 74(Pt 12), 2539\u20132547 (1993).","journal-title":"J Gen Virol"},{"key":"BFsrep22492_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/0042-6822(79)90502-6","volume":"95","author":"MC Hsu","year":"1979","unstructured":"Hsu, M. C., Scheid, A. & Choppin, P. W. Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology 95, 476\u2013491 (1979).","journal-title":"Virology"},{"key":"BFsrep22492_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/jvi.11.2.263-271.1973","volume":"11","author":"A Scheid","year":"1973","unstructured":"Scheid, A. & Choppin, P. W. Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol 11, 263\u2013271 (1973).","journal-title":"J Virol"},{"key":"BFsrep22492_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0042-6822(77)90412-3","volume":"77","author":"Y Nagai","year":"1977","unstructured":"Nagai, Y. & Klenk, H. D. Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology 77, 125\u2013134 (1977).","journal-title":"Virology"},{"key":"BFsrep22492_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0042-6822(76)90178-1","volume":"72","author":"Y Nagai","year":"1976","unstructured":"Nagai, Y., Klenk, H. D. & Rott, R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72, 494\u2013508 (1976).","journal-title":"Virology"},{"key":"BFsrep22492_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0042-6822(74)90187-1","volume":"57","author":"A Scheid","year":"1974","unstructured":"Scheid, A. & Choppin, P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57, 475\u2013490 (1974).","journal-title":"Virology"},{"key":"BFsrep22492_CR9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1128\/jvi.12.6.1457-1465.1973","volume":"12","author":"M Homma","year":"1973","unstructured":"Homma, M. & Ouchi, M. Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol 12, 1457\u20131465 (1973).","journal-title":"J Virol"},{"key":"BFsrep22492_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1473-3099(04)01222-8","volume":"4","author":"P Das","year":"2004","unstructured":"Das, P. Revolutionary vaccine technology breaks the cold chain. Lancet Infect Dis 4, 719 (2004).","journal-title":"Lancet Infect Dis"},{"key":"BFsrep22492_CR11","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1016\/j.vaccine.2007.02.052","volume":"25","author":"DM Matthias","year":"2007","unstructured":"Matthias, D. M., Robertson, J., Garrison, M. M., Newland, S. & Nelson, C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 25, 3980\u20133986 (2007).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.vaccine.2006.08.017","volume":"25","author":"C Nelson","year":"2007","unstructured":"Nelson, C. et al. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 25, 433\u2013437 (2007).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR13","first-page":"33","volume":"19","author":"P Milhomme","year":"1993","unstructured":"Milhomme, P. Cold chain study: danger of freezing vaccines. Can Commun Dis Rep 19, 33\u201338 (1993).","journal-title":"Can Commun Dis Rep"},{"key":"BFsrep22492_CR14","first-page":"99","volume":"82","author":"CM Nelson","year":"2004","unstructured":"Nelson, C. M. et al. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull World Health Organ 82, 99\u2013105 (2004).","journal-title":"Bull World Health Organ"},{"key":"BFsrep22492_CR15","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0264-410X(01)00433-9","volume":"20","author":"S Setia","year":"2002","unstructured":"Setia, S. et al. Frequency and causes of vaccine wastage. Vaccine 20, 1148\u20131156 (2002).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR16","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.vaccine.2011.04.079","volume":"29","author":"LD Schlehuber","year":"2011","unstructured":"Schlehuber, L. D. et al. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay. Vaccine 29, 5031\u20135039 (2011).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF01317812","volume":"47","author":"B Lomniczi","year":"1975","unstructured":"Lomniczi, B. Thermostability of Newcastle disease virus strains of different virulence. Arch Virol 47, 249\u2013255 (1975).","journal-title":"Arch Virol"},{"key":"BFsrep22492_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-1135(99)00069-3","volume":"68","author":"Z Bensink","year":"1999","unstructured":"Bensink, Z. & Spradbrow, P. Newcastle disease virus strain I2\u2013a prospective thermostable vaccine for use in developing countries. Veterinary microbiology 68, 131\u2013139 (1999).","journal-title":"Veterinary microbiology"},{"key":"BFsrep22492_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1751-0813.1967.tb04764.x","volume":"43","author":"GC Simmons","year":"1967","unstructured":"Simmons, G. C. The isolation of Newcastle disease virus in Queensland. Aust Vet J 43, 29\u201330 (1967).","journal-title":"Aust Vet J"},{"key":"BFsrep22492_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.19182\/remvt.8909","volume":"45","author":"V Nguyen Ba","year":"1992","unstructured":"Nguyen Ba, V. [Evaluation of the thermo-tolerability of the lyophilized V4 vaccine against Newcastle disease]. Rev Elev Med Vet Pays Trop 45, 235\u2013240 (1992).","journal-title":"Rev Elev Med Vet Pays Trop"},{"key":"BFsrep22492_CR21","first-page":"2688","volume":"15","author":"GON Echeonwu","year":"2008","unstructured":"Echeonwu, G. O. N. et al. Survival of Newcastle disease virus (NDV) strain V4-UPM coated on three grain offal and exposed to room temperature. African Journal of Biotech 15, 2688\u20132692 (2008a).","journal-title":"African Journal of Biotech"},{"key":"BFsrep22492_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/03079459108418811","volume":"20","author":"J Jagne","year":"1991","unstructured":"Jagne, J., Aini, I., Schat, K. A., Fennell, A. & Touray, O. Vaccination of village chickens in The Gambia against Newcastle disease using the heat-resistant, food-pelleted V4 vaccine. Avian Pathol 20, 721\u2013724 (1991).","journal-title":"Avian Pathol"},{"key":"BFsrep22492_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0167-5877(97)00065-2","volume":"34","author":"TD Tu","year":"1998","unstructured":"Tu, T. D., Phuc, K. V., Dinh, N. T., Quoc, D. N. & Spradbrow, P. B. Vietnamese trials with a thermostable Newcastle disease vaccine (strain I2) in experimental and village chickens. Prev Vet Med 34, 205\u2013214 (1998).","journal-title":"Prev Vet Med"},{"key":"BFsrep22492_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0167-5877(99)00089-6","volume":"43","author":"PN Wambura","year":"2000","unstructured":"Wambura, P. N., Kapaga, A. M. & Hyera, J. M. Experimental trials with a thermostable Newcastle disease virus (strain I2) in commercial and village chickens in Tanzania. Prev Vet Med 43, 75\u201383 (2000).","journal-title":"Prev Vet Med"},{"key":"BFsrep22492_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/10425179509074699","volume":"6","author":"WS Tan","year":"1995","unstructured":"Tan, W. S., Lau, C. H., Ng, B. K., Ibrahim, A. L. & Yusoff, K. Nucleotide sequence of the haemagglutinin-neuraminidase (HN) gene of a Malaysian heat resistant viscerotropic-velogenic Newcastle disease virus (NDV) strain AF2240. DNA Seq 6, 47\u201350 (1995).","journal-title":"DNA Seq"},{"key":"BFsrep22492_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/03079459608419185","volume":"25","author":"K Yusoff","year":"1996","unstructured":"Yusoff, K., Tan, W. S., Lau, C. H., Ng, B. K. & Ibrahim, A. L. Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4(UPM). Avian Pathol 25, 837\u2013844 (1996).","journal-title":"Avian Pathol"},{"key":"BFsrep22492_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.vetmic.2005.10.041","volume":"114","author":"JA Kattenbelt","year":"2006","unstructured":"Kattenbelt, J. A., Meers, J. & Gould, A. R. Genome sequence of the thermostable Newcastle disease virus (strain I-2) reveals a possible phenotypic locus. Veterinary microbiology 114, 134\u2013141 (2006).","journal-title":"Veterinary microbiology"},{"key":"BFsrep22492_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11262-012-0871-1","volume":"46","author":"G Wen","year":"2013","unstructured":"Wen, G. et al. Complete genome sequence and molecular characterization of thermostable Newcastle disease virus strain TS09-C. Virus Genes 46, 542\u2013545 (2013).","journal-title":"Virus Genes"},{"key":"BFsrep22492_CR29","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1128\/JVI.00666-14","volume":"88","author":"A Paldurai","year":"2014","unstructured":"Paldurai, A. et al. Evaluation of the contributions of individual viral genes to newcastle disease virus virulence and pathogenesis. J Virol 88, 8579\u20138596 (2014).","journal-title":"J Virol"},{"key":"BFsrep22492_CR30","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.73.6.5001-5009.1999","volume":"73","author":"BP Peeters","year":"1999","unstructured":"Peeters, B. P., de Leeuw, O. S., Koch, G. & Gielkens, A. L. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73, 5001\u20135009 (1999).","journal-title":"J Virol"},{"key":"BFsrep22492_CR31","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1128\/JVI.02049-09","volume":"84","author":"SH Kim","year":"2010","unstructured":"Kim, S. H. & Samal, S. K. Role of untranslated regions in regulation of gene expression, replication and pathogenicity of Newcastle disease virus expressing green fluorescent protein. J Virol 84, 2629\u20132634 (2010).","journal-title":"J Virol"},{"key":"BFsrep22492_CR32","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1128\/JVI.00519-11","volume":"85","author":"J Ge","year":"2011","unstructured":"Ge, J. et al. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic and provides long-lasting protection in dogs and cats. J Virol 85, 8241\u20138252 (2011).","journal-title":"J Virol"},{"key":"BFsrep22492_CR33","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1128\/JVI.01321-14","volume":"88","author":"W Zhao","year":"2014","unstructured":"Zhao, W. et al. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. J Virol 88, 8397\u20138406 (2014).","journal-title":"J Virol"},{"key":"BFsrep22492_CR34","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1128\/JVI.02036-10","volume":"85","author":"J Maamary","year":"2011","unstructured":"Maamary, J. et al. Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice. J Virol 85, 2235\u20132246 (2011).","journal-title":"J Virol"},{"key":"BFsrep22492_CR35","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.1016\/j.vaccine.2011.09.007","volume":"29","author":"H Hu","year":"2011","unstructured":"Hu, H. et al. Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine 29, 8624\u20138633 (2011).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR36","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1099\/vir.0.000067","volume":"96","author":"G Wen","year":"2015","unstructured":"Wen, G. et al. Development of a Novel Thermostable Newcastle Disease Virus Vaccine Vector for Expression of a Heterologous Gene. J Gen Virol 96, 1219\u20131228 (2015).","journal-title":"J Gen Virol"},{"key":"BFsrep22492_CR37","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/JVI.78.8.4176-4184.2004","volume":"78","author":"Z Huang","year":"2004","unstructured":"Huang, Z. et al. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 78, 4176\u20134184 (2004).","journal-title":"J Virol"},{"key":"BFsrep22492_CR38","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1128\/JVI.00536-09","volume":"83","author":"SK Khattar","year":"2009","unstructured":"Khattar, S. K., Yan, Y., Panda, A., Collins, P. L. & Samal, S. K. A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity. J Virol 83, 7779\u20137782 (2009).","journal-title":"J Virol"},{"key":"BFsrep22492_CR39","unstructured":"Lamb, R. & Parks, G. In Fields Virology, 5th ed (eds Knipe, D. M. et al.) 1449\u20131496 (Lippincott Williams & Wilkins, 2007)."},{"key":"BFsrep22492_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1006\/viro.1993.1541","volume":"196","author":"T Sergel","year":"1993","unstructured":"Sergel, T., McGinnes, L. W. & Morrison, T. G. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology 196, 831\u2013834 (1993).","journal-title":"Virology"},{"key":"BFsrep22492_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micpath.2003.07.003","volume":"36","author":"A Panda","year":"2004","unstructured":"Panda, A., Huang, Z., Elankumaran, S., Rockemann, D. D. & Samal, S. K. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 36, 1\u201310 (2004).","journal-title":"Microb Pathog"},{"key":"BFsrep22492_CR42","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1016\/j.vaccine.2010.04.112","volume":"28","author":"D Chen","year":"2010","unstructured":"Chen, D. et al. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method. Vaccine 28, 5093\u20135099 (2010).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR43","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1016\/j.vaccine.2007.06.065","volume":"25","author":"A Levin","year":"2007","unstructured":"Levin, A., Levin, C., Kristensen, D. & Matthias, D. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh. Vaccine 25, 6945\u20136957 (2007).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR44","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1073\/pnas.1300233110","volume":"110","author":"G Wang","year":"2013","unstructured":"Wang, G. et al. Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions. Proc Natl Acad Sci USA 110, 7619\u20137624 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep22492_CR45","doi-asserted-by":"crossref","unstructured":"Manoharan, V. K., Khattar, S. K., Paldurai, A., Kim, S. H. & Samal, S. K. A Y527A mutation in the fusion protein of Newcastle disease virus strain LaSota leads to a hyperfusogenic virus with increased replication and immunogenicity. J Gen Virol, doi: 10.1099\/jgv.0.000350 (2015).","DOI":"10.1099\/jgv.0.000350"},{"key":"BFsrep22492_CR46","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.vaccine.2014.01.020","volume":"32","author":"J Ge","year":"2014","unstructured":"Ge, J. et al. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease. Vaccine 32, 1514\u20131521 (2014).","journal-title":"Vaccine"},{"key":"BFsrep22492_CR47","unstructured":"Alexander, D. J. Newcastle disease virus and other avian paramyxoviruses. In Swayne D., Glisson J. R., Jackwood M. W., Pearson J. E., Reed W. M. A laboratory manual for the isolation and identification of avian pathogens. 4th ed Kennett Square, PA: American Association of Avian Pathologists. (1998)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep22492","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:30:39Z","timestamp":1672839039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep22492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,20]]}},"alternative-id":["BFsrep22492"],"URL":"https:\/\/doi.org\/10.1038\/srep22492","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]},"assertion":[{"value":"13 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22492"}}